Literature DB >> 307141

[Indomethacin retard 75 mg in the treatment of coxarthrosis].

H Schlemmer, H D Braun.   

Abstract

A single dose of 75 mg Sustained-Release Indomethacin proved to be an effective medication in the treatment of osteoarthritis of the hip. It was generally well tolerated; two patients reported moderate gastrointestinal side effects, no CNS related side effects. The gastric tolerance appeared to be better than with Amuno. The convenience of the single dose therapy was spontaneously expressed by all patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307141

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  1 in total

1.  A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations.

Authors:  K R Adams; L D Halliday; R G Sibeon; N Baber; T Littler; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.